{
    "clinical_study": {
        "@rank": "1661", 
        "acronym": "NESCI", 
        "arm_group": [
            {
                "arm_group_label": "electrical stimulation", 
                "arm_group_type": "Experimental", 
                "description": "Compex 3 professional NMES for 60' per day"
            }, 
            {
                "arm_group_label": "control", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "Critically ill patients with a predicted prolonged ICU stay will receive neuromuscular\n      electrical stimulation (NMES) of one quadriceps muscle. Whether the dominant or non-dominant\n      side will be stimulated is chosen randomly by using opaque sealed envelopes. The patients\n      will receive electrical stimulation for 1h for 7 consecutive days. The stimulated and\n      non-stimulated side will be compared for it's thickness (by using ultrasound imaging),\n      muscle strength if the patients are awake and cooperative (using the medical research\n      council scale and handheld dynamometry) and a muscle biopsy will be taken. As a primary\n      outcome the investigators hypothesize that electrical stimulation will preserve muscle mass\n      with respect to the non-stimulated quadriceps. As secondary outcomes the investigators\n      hypothesize that electrical stimulation can reduce muscle strength loss and leads to a\n      better protein balance and thicker muscle fibers in the stimulated quadriceps."
        }, 
        "brief_title": "NMES in Critically Ill Patients", 
        "condition": "Critically Ill Patients With a Predicted Prolonged ICU Stay", 
        "condition_browse": {
            "mesh_term": "Critical Illness"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All adult ICU patients with a predicted prolonged ICU stay\n\n        Exclusion Criteria:\n\n          -  Preexisting neuromuscular disease, polyneuropathy or myopathy (e.g. Guillain-Barr\u00e9,\n             myasthenia gravis, Amyotrophic Lateral Sclerosis, paraplegia, multiple sclerosis, \u2026)\n\n          -  Receiving neuromuscular blocking agents\n\n          -  Musculoskeletal conditions of the pelvis and/or lower limb (e.g. fractures, skin\n             disease )\n\n          -  Focal neurological conditions of the pelvis and/or lower limb\n\n          -  Skin disease (e.g. burns)\n\n          -  Presence of a pace-maker or defibrillator\n\n          -  Hemodynamic or Respiratory Instability, active cardiac ischemia\n\n          -  High fever (>39\u00b0)\n\n          -  Pregnancy\n\n          -  Brain death\n\n          -  Intracranial pressure >20 mmHg\n\n          -  An anticipated fatal outcome\n\n          -  Psychiatric disorders or severe agitation\n\n          -  Re-admission to the ICU"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02133300", 
            "org_study_id": "u0064027"
        }, 
        "intervention": {
            "arm_group_label": "electrical stimulation", 
            "intervention_name": "electrical stimulation", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 4, 2014", 
        "location": {
            "contact": {
                "email": "johan.segers@faber.kuleuven.be", 
                "last_name": "Johan Segers, MSc", 
                "phone": "+3216342356"
            }, 
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium", 
                    "state": "Vlaams-Brabant", 
                    "zip": "3001"
                }, 
                "name": "University Hospitals Leuven"
            }, 
            "investigator": [
                {
                    "last_name": "Johan Segers, MSc", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Rik Gosselink, PhD, PT", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Greet Hermans, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ilse Vanhorebeek, MD, PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "Neuromuscular Electrical Stimulation in Critically Ill Patients", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Catholic University Leuven", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Ultrasound measure in cm", 
                "measure": "Muscle thickness", 
                "safety_issue": "No", 
                "time_frame": "pre-intervention period"
            }, 
            {
                "description": "Ultrasound measure in cm", 
                "measure": "Muscle thickness", 
                "safety_issue": "No", 
                "time_frame": "post intervention period"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02133300"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Katholieke Universiteit Leuven", 
            "investigator_full_name": "Johan Segers", 
            "investigator_title": "M.Sc.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "MRC: scale HHD: MicroFet, in kg Force", 
                "measure": "Muscle strength (MRC & HHD)", 
                "safety_issue": "No", 
                "time_frame": "pre intervention period"
            }, 
            {
                "description": "biopsy using Bergstr\u00f6m-Stille 5mm needles", 
                "measure": "Muscle fiber thickness", 
                "safety_issue": "No", 
                "time_frame": "post intervention period"
            }, 
            {
                "description": "MRC: scale HHD: MicroFET, in kg Force", 
                "measure": "Muscle strength (MRC & HHD)", 
                "safety_issue": "No", 
                "time_frame": "post intervention period"
            }, 
            {
                "description": "biopsy using Bergstr\u00f6m-Stille 5mm needles", 
                "measure": "Protein balance", 
                "safety_issue": "No", 
                "time_frame": "post intervention"
            }
        ], 
        "source": "Katholieke Universiteit Leuven", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Katholieke Universiteit Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}